Effectiveness and safety of non–vitamin K oral anticoagulants in comparison to phenprocoumon: data from 61,000 patients with atrial fibrillation
SH Hohnloser, E Basic, C Hohmann… - Thrombosis and …, 2018 - thieme-connect.com
All pivotal trials have evaluated non–vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
SH Hohnloser, E Basic… - Thrombosis and …, 2018 - pubmed.ncbi.nlm.nih.gov
All pivotal trials have evaluated non-vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation.
SH Hohnloser, E Basic, C Hohmann… - Thrombosis and …, 2018 - europepmc.org
All pivotal trials have evaluated non-vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
SH Hohnloser, E Basic… - Thrombosis and …, 2018 - epub.ub.uni-muenchen.de
All pivotal trials have evaluated non-vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
SH Hohnloser, E Basic, C Hohmann… - Thromb …, 2018 - kups.ub.uni-koeln.de
All pivotal trials have evaluated non-vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non–Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
SH Hohnloser, E Basic, C Hohmann… - Thrombosis and …, 2018 - thieme-connect.com
All pivotal trials have evaluated non–vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
SH Hohnloser, E Basic, C Hohmann… - Thromb …, 2018 - kups.ub.uni-koeln.de
All pivotal trials have evaluated non-vitamin K oral antagonists (NOACs) against warfarin.
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …
However, in some regions of the world, phenprocoumon is the most widely used vitamin K …